Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort

Publisher: John Wiley & Sons Inc

E-ISSN: 1445-5994|45|10|1054-1065

ISSN: 1444-0903

Source: INTERNAL MEDICINE JOURNAL, Vol.45, Iss.10, 2015-10, pp. : 1054-1065

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract